SCHEMBL923382

SCHEMBL923382

CC(NC(=O)O)c1c(-c2nnc(C(C)(C)C)o2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1

nearest known ligand 0.85

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 8/20 0.76

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5050219 0.95 CNR2 (0.69) CNR2
SCHEMBL923472 0.87 CNR2 (0.67) CNR2
SCHEMBL923163 0.87 CNR2 (1.00) CNR2
SCHEMBL923030 0.86 CNR2 (1.00) CNR2
SCHEMBL922776 0.85 CNR2 (1.00) CNR2
SCHEMBL925904 0.84 CNR2 (0.87) CNR2
SCHEMBL4004150 0.84 CNR2 (0.76) CNR2
SCHEMBL923457 0.83 CNR2 (0.82) CNR2
SCHEMBL4133206 0.83 CNR2 (0.79) CNR2
SCHEMBL5047769 0.83 CNR2 (0.57) CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7875647-B2 and inverse agonist; 2-(5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazol-3-yl)-5-(pyridin-4-yl)-1,3,4-oxadiazole; obesity and obesity-related metabolic disorders GREEN CROSS CORPORATION (KR) 2011-01-25 US disclosed